United Therapeutics UTHR
NASDAQ UTHR
$506.95 +8.98 (+1.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

United Therapeutics (UTHR) Total Debt (QoQ) (2010 - 2025)

Analysis

United Therapeutics (UTHR) Total Debt (QoQ) (2010 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn
10 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -33.33%
Dec 31, 2024 -25.00%
Sep 30, 2024 -20.00%
Jun 30, 2024 -16.67%
Mar 31, 2024 -14.29%
Dec 31, 2023 -12.50%
Sep 30, 2023 0.00%
Jun 30, 2023 0.00%
Mar 31, 2023 0.00%
Dec 31, 2022 0.00%
Sep 30, 2022 0.00%
Jun 30, 2022 0.00%
Mar 31, 2022 0.00%
Dec 31, 2021 0.00%
Sep 30, 2021 0.00%
Jun 30, 2021 0.00%
Mar 31, 2021 0.00%
Dec 31, 2020 0.00%
Sep 30, 2020 0.00%
Jun 30, 2020 0.00%